Adherence of Stalevo, Entacapone and Levodopa
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00245700|
Recruitment Status : Completed
First Posted : October 28, 2005
Last Update Posted : May 23, 2008
To test if combining two antiparkinson drugs into a single tablet improves accuracy of medicine intake by the patient.
To test if patients with Parkinson's disease who take medicines at regular time intervals have smoother symptom control.
|Condition or disease|
|Study Type :||Observational|
|Enrollment :||14 participants|
|Official Title:||Study of Adherence of Stalevo, Entacapone and Levodopa|
|Study Start Date :||April 2005|
|Actual Study Completion Date :||July 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00245700
|Southern General Hospital|
|Glasgow, Scotland, United Kingdom, G51 4TF|
|Principal Investigator:||Donald G Grosset, MBChB, MD|